fluorouracil has been researched along with hyaluronoglucosaminidase in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Czejka, MJ; Jäger, W; Schüller, J | 1 |
| Dockery, GL; Nilson, RZ | 1 |
| Balletto, N; Bocchio, MM; Carrabetta, S; Civalleri, D; De Cian, F; Esposito, M; Mondini, G; Vannozzi, MO | 1 |
| Billotte, C; Dubovy, S; Fernandez, V; Fragoso, MA; Lamar, P; Orozco, MA; Parel, JM; Willcox, M | 1 |
| Dygai, AM; Ermakova, NN; Firsova, TV; Khrichkova, TY; Minakova, MY; Simanina, EV; Stavrova, LA; Udut, EV; Zhdanov, VV; Zyuz'kov, GN | 1 |
| Al-Arfaj, AA; Murugan, AM; Raj, V; Rajan, M | 1 |
| Benner, A; Bläker, H; Brenner, H; Burwinkel, B; Chang-Claude, J; Herpel, E; Hoffmeister, M; Jansen, L; Pfütze, K; Ulrich, A; Ulrich, CM; Yang, R | 1 |
| Corrie, PG; Doherty, GJ; Tempero, M | 1 |
| An, Y; He, X; Jiang, H; Lu, H; Shi, X; Yu, X | 1 |
| Bekaii-Saab, T | 1 |
| Behl, D; Chiorean, EG; Gaur, R; Guthrie, KA; Hingorani, SR; Hochster, HS; Kortmansky, JS; Lacy, J; McDonough, SL; Mehan, PT; Philip, PA; Ramanathan, RK; Seery, T; Shields, AF; Thumar, J | 1 |
| Eisert, L; Nast, A | 1 |
3 trial(s) available for fluorouracil and hyaluronoglucosaminidase
| Article | Year |
|---|---|
[Effects of adjuvant hyaluronidase in tumors refractory to chemotherapy. Review of the literature and pharmacokinetics of cisplatin after regional administration in animals and humans].
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma 256, Walker; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Cisplatin; Colorectal Neoplasms; Fluorouracil; Humans; Hyaluronoglucosaminidase; Infusions, Intra-Arterial; Infusions, Intravenous; Injections, Intraperitoneal; Liver Neoplasms; Male; Peritoneal Neoplasms; Rats; Rats, Sprague-Dawley; Time Factors | 1997 |
HALO-109-301: a Phase III trial of PEGPH20 (with gemcitabine and nab-paclitaxel) in hyaluronic acid-high stage IV pancreatic cancer.
Topics: Adult; Aged; Albumins; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Gemcitabine; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Oxaliplatin; Paclitaxel; Pancreatic Neoplasms; Recombinant Proteins; Tumor Microenvironment | 2018 |
Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Immunohistochemistry; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Oxaliplatin; Pancreatic Neoplasms; Survival Rate | 2019 |
9 other study(ies) available for fluorouracil and hyaluronoglucosaminidase
| Article | Year |
|---|---|
Influence of hyaluronidase on the blood plasma levels of 5-fluorouracil in patients.
Topics: Fluorouracil; Humans; Hyaluronoglucosaminidase; Injections, Intra-Arterial; Liver Neoplasms; Male; Middle Aged | 1990 |
Intralesional injections.
Topics: Adrenal Cortex Hormones; Bleomycin; Fluorouracil; Foot Dermatoses; Foot Diseases; Humans; Hyaluronoglucosaminidase; Injections, Subcutaneous; Sclerosing Solutions | 1986 |
Efficacy of various drugs in the prevention of posterior capsule opacification: experimental study of rabbit eyes.
Topics: Acetates; Acetic Acid; Animals; Capsulorhexis; Cataract; Cell Proliferation; Drug Combinations; Edetic Acid; Epithelial Cells; Female; Fluorouracil; Hyaluronoglucosaminidase; Lens Capsule, Crystalline; Minerals; Mitomycin; Ophthalmic Solutions; Phacoemulsification; Postoperative Complications; Rabbits; Sodium Chloride | 2004 |
Effect of transplantation of peripheral blood mononuclears obtained using granulocytic colony-stimulating factor and hyaluronidase on regeneration of hemopoietic tissue during myelosuppression.
Topics: Animals; Bone Marrow; Cell Transplantation; Fluorouracil; Granulocyte Colony-Stimulating Factor; Hyaluronoglucosaminidase; Male; Mice; Monocytes | 2009 |
Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
Topics: Antimetabolites, Antineoplastic; Cell Line, Tumor; Cell Survival; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Fluorouracil; Gelatin; Humans; Hyaluronoglucosaminidase; Nanocomposites; Polyethylene Glycols | 2013 |
Methylation status at HYAL2 predicts overall and progression-free survival of colon cancer patients under 5-FU chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Cell Adhesion Molecules; Colonic Neoplasms; CpG Islands; Disease-Free Survival; DNA Methylation; Female; Fluorouracil; Follow-Up Studies; GPI-Linked Proteins; Humans; Hyaluronoglucosaminidase; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prognosis; Regression Analysis; Treatment Outcome | 2015 |
Hyaluronidase Enzyme-responsive Targeted Nanoparticles for Effective Delivery of 5-Fluorouracil in Colon Cancer.
Topics: Animals; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Apoptosis; Colonic Neoplasms; Drug Compounding; Drug Delivery Systems; Drug Liberation; Fluorouracil; Histone Acetyltransferases; HT29 Cells; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Mice; Mice, Inbred BALB C; Nanoparticles; Silicates; Xenograft Model Antitumor Assays | 2018 |
New guideline-sanctioned and emerging interventions for pancreatic cancer.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Deoxycytidine; Drug Resistance, Neoplasm; Fluorouracil; Gemcitabine; Histone Acetyltransferases; Humans; Hyaluronoglucosaminidase; Irinotecan; Leucovorin; Neoplasm Metastasis; Oxaliplatin; Pancreas; Pancreatic Neoplasms | 2018 |
Treatment of extensive, recalcitrant keloids using a combination of intralesional cryosurgery, triamcinolone, 5-fluorouracil and hyaluronidase.
Topics: Adrenal Cortex Hormones; Brachytherapy; Cryosurgery; Cryotherapy; Fluorouracil; Humans; Hyaluronoglucosaminidase; Injections, Intralesional; Keloid; Triamcinolone | 2019 |